Tomasz Koczorowski

Dr. Tomasz Koczorowski

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 September 2021 in Applied Sciences
Verified
Journal Article
Open access
PDF file
RKRafal Krakowiak
Rafal Krakowiak
JMJoanna Musiał
Joanna Musiał
Paweł BakunPaweł Bakun
Paweł Bakun
MSMarcin Spychała
Marcin Spychała
BCBeata Czarczynska-Goslinska
Beata Czarczynska-Goslinska
TGTomasz Gośliński
Tomasz Gośliński
Contamination of the environment has been a growing problem in recent years. Due to the rapid growth in human population, the expansion of cities, along with the development of industry, more and more dangerous chemicals end up in the environment, especially in soil and water. For the most part, it is not possible to effectively remove chemicals through traditional remediation techniques, because those used in treatment plants are not specifically designed for this purpose. Therefore, new approaches for water remediation are in great demand. Many efforts have been focused on applications of photocatalysis for the remediation of chemical pollutants including drugs. Titanium(IV) oxide nanoparticles have particularly been considered as potential photocatalysts due to their favorable properties. In this article, we present the problem of emerging contaminants including drugs and discuss the use of photocatalysts based on titanium(IV) oxide nanoparticles for their degradation. A wide selection of materials, starting from bare TiO2, via its hybrid and composite materials, are discussed including those based on carbonaceous materials or connections with macrocyclic structures. Examples of photodegradation experiments on TiO2-based materials including those performed with various active pharmaceutical ingredients are also included.

2 May 2023 in Nanomaterials
Verified
Journal Article
Open access
PDF file
SSStepan Sysak
Stepan Sysak
BCBeata Czarczynska-Goslinska
Beata Czarczynska-Goslinska
PSPiotr Szyk
Piotr Szyk
TKTomasz Koczorowski
Tomasz Koczorowski
DMDariusz Mlynarczyk
Dariusz Mlynarczyk
TGTomasz Gośliński
Tomasz Gośliński
Flavonoids are polyphenolic compounds widely occurring throughout the plant kingdom. They are biologically active and have many medical applications. Flavonoids reveal chemopreventive, anticarcinogenic, and antioxidant properties, as well as being able to modulate the immune system response and inhibit inflammation, angiogenesis, and metastasis. Polyphenols are also believed to reverse multidrug resistance via various mechanisms, induce apoptosis, and activate cell death signals in tumor cells by modulating cell signaling pathways. The main limitation to the broader usage of flavonoids is their low solubility, poor absorption, and rapid metabolism. To tackle this, the combining of flavonoids with nanocarriers could improve their bioavailability and create systems of wider functionalities. Recently, interest in hybrid materials based on combinations of metal nanoparticles with flavonoids has increased due to their unique physicochemical and biological properties, including improved selectivity toward target sites. In addition, flavonoids have further utilities, even in the initial step of preparation of metal nanomaterials. The review offers knowledge on multiple possibilities of the synthesis of flavonoid-metal nanoparticle conjugates, as well as presents some of their features such as size, shape, surface charge, and stability. The flavonoid-metal nanoparticles are also discussed regarding their biological properties and potential medical applications.

1 July 2017 in Journal of Inorganic Biochemistry
Verified
Journal Article
Closed access
JDJolanta Dlugaszewska
Jolanta Dlugaszewska
WSWojciech Szczolko
Wojciech Szczolko
TKTomasz Koczorowski
Tomasz Koczorowski
PSPaulina Skupin-Mrugalska
Paulina Skupin-Mrugalska
ATAnna Teubert
Anna Teubert
TGTomasz Gośliński
Tomasz Gośliński

26 May 2021 in Applied Sciences
Verified
Journal Article
Open access
PDF file
Magdalena Cerbin-KoczorowskaMagdalena Cerbin-Koczorowska
Magdalena Cerbin-Koczorowska
Magdalena Waszyk-NowaczykMagdalena Waszyk-Nowaczyk
Magdalena Waszyk-Nowaczyk
Paweł BakunPaweł Bakun
Paweł Bakun
TGTomasz Gośliński
Tomasz Gośliński
TKTomasz Koczorowski
Tomasz Koczorowski
Green tea extract (GTE) is one of the most popular beverages globally, traditionally prepared from Camelia sinensis leaves. Therefore, it is beneficial to define the impact of GTE and its ingredients on the human organism. Epigallocatechin-3-O-gallate (EGCG) is the most abundant catechin in green tea leaves, belonging to the group of tannins and flavonoids, demonstrating pharmacological activity, but so far, it has not been applied as a drug. This is because EGCG does not present sufficient stability and quickly decomposes through epimerization or autooxidation mechanisms under the influence of light, temperature, changes in pH, or the presence of oxygen. Another limiting factor is EGCG’s low bioavailability after oral administration. Nevertheless, the growing market of dietary supplements together with increasing growing consumption of green tea extracts should prompt us to pay more attention to the safety of both EGCG itself, as well as its influence on other simultaneously used drugs. Previously published data confirm the relationship between healthcare professionals’ access to professional knowledge and their willingness to engage in patient education. For this reason, in this review article, we report the formulations of EGCG and GTE, discuss the data on the safety of EGCG and its possible interactions with drugs, as well as gather various recommendations from medical specialists. Particular attention should be paid to the consumption of green tea during pregnancy and breastfeeding, as well as in the elderly. Patients taking clozapine, digoxin, and warfarin should avoid consuming GTE extracts and dietary supplements containing EGCG. Professional consultation seems especially important for patients treated with statins, calcium channel blockers, or sildenafil.

1 April 2012 in Tetrahedron Letters
Verified
Journal Article
Closed access
WSWojciech Szczolko
Wojciech Szczolko
Lukasz SobottaLukasz Sobotta
Lukasz Sobotta
PFPiotr Fita
Piotr Fita
TKTomasz Koczorowski
Tomasz Koczorowski
MMMichal Mikus
Michal Mikus
TGTomasz Gośliński
Tomasz Gośliński

1 January 2019 in Journal of Photochemistry and Photobiology A: Chemistry
Verified
Journal Article
Closed access
Lukasz SobottaLukasz Sobotta
Lukasz Sobotta
JDJolanta Dlugaszewska
Jolanta Dlugaszewska
DZDaniel Ziental
Daniel Ziental
WSWojciech Szczolko
Wojciech Szczolko
TKTomasz Koczorowski
Tomasz Koczorowski
JMJadwiga Mielcarek
Jadwiga Mielcarek